DAYTON, Ohio (WDTN) -- It's been nearly three weeks since the U.S. Supreme Court heard arguments about the abortion medication Mifepristone, and a decision awaits. Access to the medication remains up to SCOTUS and justices are considering whether FDA rules need to be rolled back. This would change the course of how patients take the [] Read this story
